DCVax-L in the Treatment of Glioblastoma: Phase 3 Passed and prospects as a new Standard of Care
In this article, I try to answer, as precisely and completely as possible, the questions that I received through the…
Stories and useful information to fight this brain tumor
In this article, I try to answer, as precisely and completely as possible, the questions that I received through the…
Before publishing the article on the latest research on Glioblastoma that should be released in the next few days, following…
On February 23, 2025, in Sala Lelio Luttazzi, Magazzino 26, Trieste hosted a day dedicated to raising awareness and supporting…
Dear all, waiting for the next issue on research news that we will publish at the end of the month,…
As promised, we report below the Charter of Rights of Patients with Brain Tumor that you can find in the…
As you know, Glioblastoma.IT ODV has long been part of the International Brain Tumour Alliance (IBTA), which continues to serve…
We are pleased to announce the arrival of Gliobot Next Generation, our chatbot designed to provide support and information to glioblastoma patients,…
It is with great pleasure that I announce the first video conference of 2024 which aims to clarify immunotherapy for…
Several people ask me about molecular biomarker testing, sometimes called genome next-generation sequencing (NGS). Although the diagnosis of glioblastoma is…